April 29th 2025
Jon Giles, MD, speaks to the power of personalized medicine and multidisciplinary care to enhance treatment for patients with rheumatoid arthritis (RA).
Perceived Necessity vs Implementation of Psychological Support for Patients With RA in Japan
July 22nd 2023Patient-centered care (PCC) is a major part of a patient’s daily life that addresses their psychological needs, among other needs and preferences. Quality PCC has been recognized as important in clinical practice; however, implementation rates remain comparatively low.
Read More
Dr Emma Guttman-Yassky: Strong Real-World Results of Biologics, JAK Inhibitors in AD
July 16th 2023Some of the results with biologics and Janus kinase (JAK) inhibitors for atopic dermatitis have been better in practice compared with clinical trials, said Emma Guttman-Yassky, MD, PhD, FAAD, of the Icahn School of Medicine at Mount Sinai.
Watch
Patient Education Can Prevent Nocebo Effect With Adalimumab Biosimilars, Explains Laura Wingate
July 15th 2023As Humira biosimilars enter the market, patient education about biosimilars is crucial to prevent the nocebo effect when patients switch from the reference product, explained Laura Wingate, executive vice president, Education, Support, & Advocacy, Crohn's & Colitis Foundation.
Watch
Influence of Prior Authorization Requirements on Provider Clinical Decision-Making
An online survey identified that documentation requirements and communication issues with health plans are associated with providers modifying clinical decisions to avoid medication prior authorization.
Read More
Health Care Professionals’ Implicit Bias May Affect Treatment Referrals for Smokers With COPD
June 30th 2023Researchers found that health care professionals who refer patients with chronic obstructive pulmonary disease (COPD) to pulmonary rehabilitation have a negative bias toward smoking and a positive bias toward exercising, which could affect how they present rehabilitation options.
Read More
Dr James Howard Explains Mechanisms of Action of Newer Myasthenia Gravis Therapies
June 17th 2023Future myasthenia gravis therapies have different mechanisms of action than current treatments, said James F. Howard Jr, MD, professor of neurology at the University of North Carolina at Chapel Hill.
Watch
Contingency Management in a Perinatal Substance Exposure Clinic
Project CARA, a perinatal substance exposure clinic, has implemented a contingency management program that targets appointment attendance for patients with any use disorder, regardless of substance or urine drug screen results.
Read More
Mandatory Switch Policies Drive Biosimilar Uptake, Reduce Costs
June 2nd 2023Abstracts presented at EULAR 2023 highlighted the impact that a mandatory switching policy had on biosimilar uptake in British Columbia, Canada, and the lack of uptake when no such policy was in place in the United States.
Read More